Michael S. Gunter, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 2,300 shares at $3.39 ($8K) on 2011-11-29, disclosed to the SEC on 2011-11-30.
Open-market purchase of $8k HRT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.38 | 100 | $338 | 4.3% |
| 2 | $3.39 | 200 | $678 | 8.7% |
| 3 | $3.40 | 2,000 | $7K | 87.0% |
| Total | $3.40 avg | 2,300 | $8K | 100% |
| Filing → |
| HRT | BUY | 2012-12-10 | $239 | — | Filing → |
| HRT | BUY | 2012-02-14 | $1K | — | Filing → |
| HRT | BUY | 2011-12-15 | $2K | — | Filing → |